详情页 - 云南省第一人民医院机构库

当前位置：首页 > 详情页

A Prospective Cohort Study on Drug-induced Liver Injury in China（DILI-P） (DILI-P)

44| 认领 | 链接全文 |

文献详情

编号/登记号：

注册时间：

研究开始时间：

研究结束时间：

项目类型：

本院角色：

多中心研究：

招募状态：

研究疾病/适应症：

研究类型：

研究参与人：

研究单位： [1]Drug Induced Liver Disease Study Group [2]Affiliated Hospital of Hebei University of Engineering [3]Fifth Hospital of Shijiazhuang City [4]First Teaching Hospital of Tianjin University of Traditional Chinese Medicine [5]Beijing 302 Hospital [6]The First Affiliated Hospital of Henan University of Science and Technology [7]Southwest Hospital,China [8]The First Affiliated Hospital of Shanxi Medical University [9]First People's Hospital of Yunnan Province [10]The First Affiliated Hospital of Medical College,Shihezi University [11]Nanjing Chest Hospital [12]The First Affiliated Hospital of Nanchang University [13]Linyi People's Hospital [14]Hunan Chest Hospital [15]The Fifth People,Hospital of Suzhou [16]Renmin Hospital of Wuhan University [17]85 Hospital of People's Liberation Army [18]The First Affiliated Hospital of Xiamen University [19]Xiangya Hospital of Central South University [20]First Affiliated Hospital of Xinjiang Medical University

研究目的：

This is a multi-center, prospective, non-interventional cohort study . Its primary objectives are: assess DILI patients' clinical characteristics, disease progression and influencing factors in clinical practice; learn about suspected drug caused DILI,rechallenging, liver biochemical abnormalities mode, etc.